Korea warns of rare vision-loss risk linked to GLP-1 drugs
The Ministry of Food and Drug Safety issued a safety alert Wednesday to medical professionals and patients over a potential risk of a rare eye condition associated with GLP-1 obesity drugs, including popular obesity treatments Wegovy and Mounjaro. The move follows safety measures by overseas regulators concerning nonarteritic anterior ischemic optic neuropathy (NAION), a condition caused by reduced blood flow…
Full story
Read the full story at Korea Times ↗
Continue reading this story on Korea Times, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
